The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
VS Hoffmann, M Baccarani, J Hasford, D Lindörfer… - Leukemia, 2015 - nature.com
This population-based registry was designed to provide robust and updated information on
the characteristics and the epidemiology of chronic myeloid leukemia (CML). All cases of …
the characteristics and the epidemiology of chronic myeloid leukemia (CML). All cases of …
Epidemiology of chronic myeloid leukaemia: an update
M Höglund, F Sandin, B Simonsson - Annals of hematology, 2015 - Springer
National and regional population-based registries are, provided diagnostic accuracy and full
coverage of the target population, indispensible tools for epidemiological research. Chronic …
coverage of the target population, indispensible tools for epidemiological research. Chronic …
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
VS Hoffmann, M Baccarani, J Hasford, F Castagnetti… - Leukemia, 2017 - nature.com
Abstract The European Treatment and Outcome Study (EUTOS) population-based registry
includes data of all adult patients newly diagnosed with Philadelphia chromosome-positive …
includes data of all adult patients newly diagnosed with Philadelphia chromosome-positive …
Epidemiology of chronic myeloid leukaemia (CML)
M Rohrbacher, J Hasford - Best practice & research Clinical haematology, 2009 - Elsevier
Reliable epidemiological information on chronic myeloproliferative disorders (CMPDs),
notably Philadelphia (Ph)/BCR-ABL-positive chronic myeloid leukaemia (CML), is rare …
notably Philadelphia (Ph)/BCR-ABL-positive chronic myeloid leukaemia (CML), is rare …
A review of the European LeukemiaNet recommendations for the management of CML
M Baccarani, F Castagnetti, G Gugliotta, G Rosti - Annals of hematology, 2015 - Springer
Several guidelines and recommendations on the management of chronic myeloid leukemia
(CML) have been prepared by several scientific societies. The European LeukemiaNet …
(CML) have been prepared by several scientific societies. The European LeukemiaNet …
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
M Höglund, F Sandin, K Hellström… - Blood, The Journal …, 2013 - ashpublications.org
Clinical management guidelines on malignant disorders are generally based on data from
clinical trials with selected patient cohorts. In Sweden, more than 95% of all patients …
clinical trials with selected patient cohorts. In Sweden, more than 95% of all patients …
Trends in all‐cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis
AM Brunner, F Campigotto, H Sadrzadeh, BJ Drapkin… - Cancer, 2013 - Wiley Online Library
BACKGROUND Outcomes for patients with chronic myeloid leukemia (CML) have improved
after the advent of tyrosine kinase inhibitors (TKIs), which target the BCR/ABL fusion gene …
after the advent of tyrosine kinase inhibitors (TKIs), which target the BCR/ABL fusion gene …
Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Baccarani, S Pileri, JL Steegmann… - Annals of …, 2012 - annalsofoncology.org
The incidence of chronic myeloid leukemia (CML) ranges between 10 and 15
cases/106/year (age adjusted) without any major geographic or ethnic differences [1]. The …
cases/106/year (age adjusted) without any major geographic or ethnic differences [1]. The …
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008
M Björkholm, L Ohm, S Eloranta, Å Derolf… - Journal of Clinical …, 2011 - ascopubs.org
Purpose Chronic myeloid leukemia (CML) management changed dramatically with the
development of imatinib mesylate (IM), the first tyrosine kinase inhibitor targeting the BCR …
development of imatinib mesylate (IM), the first tyrosine kinase inhibitor targeting the BCR …
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
L Kalmanti, S Saussele, M Lauseker, U Proetel… - Annals of …, 2014 - Springer
Since the advent of tyrosine kinase inhibitors, the impact of age on outcome of chronic
myeloid leukemia (CML) patients has changed. We therefore analyzed patients from the …
myeloid leukemia (CML) patients has changed. We therefore analyzed patients from the …